Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
Noro R, Honda K, Nagashima K, Motoi N, Kunugi S, Matsubayashi J, Takeuchi S, Shiraishi H, Okano T, Kashiro A, Meng X, Yoshida Y, Watanabe S, Usuda J, Inoue T, Wilber H, Ikeda N, Seike M, Gemma A, Kubota K. Noro R, et al. Among authors: watanabe s. Cancer Sci. 2022 Mar;113(3):1002-1009. doi: 10.1111/cas.15228. Epub 2022 Jan 20. Cancer Sci. 2022. PMID: 34845792 Free PMC article.
A case of malignant solitary fibrous tumor of the pleura.
Yoshida Y, Watanabe S. Yoshida Y, et al. Among authors: watanabe s. Jpn J Clin Oncol. 2006 Apr;36(4):258. doi: 10.1093/jjco/hyl010. Jpn J Clin Oncol. 2006. PMID: 16684862 No abstract available.
The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma.
Kozu Y, Tsuta K, Kohno T, Sekine I, Yoshida A, Watanabe S, Tamura T, Yokota J, Suzuki K, Asamura H, Furuta K, Tsuda H. Kozu Y, et al. Among authors: watanabe s. Lung Cancer. 2011 Jul;73(1):45-50. doi: 10.1016/j.lungcan.2010.11.003. Epub 2010 Dec 3. Lung Cancer. 2011. PMID: 21129809
A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer).
Kenmotsu H, Niho S, Ito T, Ishikawa Y, Noguchi M, Tada H, Sekine I, Watanabe S, Yoshimura M, Yamamoto N, Oshita F, Kubota K, Nagai K. Kenmotsu H, et al. Among authors: watanabe s. Lung Cancer. 2014 Jun;84(3):254-8. doi: 10.1016/j.lungcan.2014.03.007. Epub 2014 Mar 13. Lung Cancer. 2014. PMID: 24679951 Clinical Trial.
10,471 results
You have reached the last available page of results. Please see the User Guide for more information.